Survival Benefit in Metastatic CRPC Study Spurs Questions on Patient Selection

By News Health
1 week Ago

(MedPage Today) — In a recent MedPage Today video, Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah in Salt Lake City, reviewed the TALAPRO-2 trial’s implications for frontline treatment of metastatic castration-resistant…

Source link : https://www.medpagetoday.com/meetingcoverage/gucsfuturefocus/114790

Author :

Publish date : 2025-03-24 15:24:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

NHS public satisfaction hits record low

US government fired researchers running a crucial drug use survey

Novel Blood Test Tracks Alzheimer's Progression

For Colorectal Cancer Screening, FIT Invitation Improved Participation

Cybersecurity Threats Remain a Problem for Older Medical Devices, House Members Say

RFK Jr.'s Massive Purge of Health Agencies Begins